Rivaroxaban
Indications: - Other specified atrial fibrillation - Venous thromboembolism Source: EML workbook import
MOQ: 1
Kes0.00
Product image unavailable
Heparin Sodium
Vendor: Marketplace supplier
Formulations:
- Parenteral > General injections > IV: 1000 IU per mL in 1 mL ampoule or vial; 20000 IU per mL in 1 mL ampoule or vial; 5000 IU per mL in 1 mL ampoule or vial
Indications:
- Acute ischaemic heart disease
- Unstable angina
- Venous thromboembolism
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Kes0.00
Availability
Supplier and price will be confirmed during RFQ.
Formulations:
- Parenteral > General injections > IV: 1000 IU per mL in 1 mL ampoule or vial; 20000 IU per mL in 1 mL ampoule or vial; 5000 IU per mL in 1 mL ampoule or vial
Indications:
- Acute ischaemic heart disease
- Unstable angina
- Venous thromboembolism
Source: EML workbook import
Similar Products
Nadroparin
Indications: - Venous thromboembolism - Acute ischaemic heart disease Source: EML workbook import
MOQ: 1
Kes0.00
Phytomenadione
Formulations: - Parenteral > General injections > IV: 10 mg per mL in ampoule; 1 mg per mL in ampoule; 2 mg per 0.2 mL in ampoule mixed micelle solution; 10 mg per mL in ampoule mixed micelle solution; 1 mg per 0.5 mL in ampoule Oral > Solid > tablet: 5 mg tablet Indications: - Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors - Haemorrhagic or haematological disorders of fetus or newborn Source: EML workbook import
MOQ: 1
Kes0.00
Protamine Sulfate
Formulations: - Parenteral > General injections > IV: 10 mg per mL in 5 mL ampoule or vial Indications: - Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors Source: EML workbook import
MOQ: 1
Kes0.00
Enoxaparin
Formulations: - Parenteral > General injections > SC: 20 mg per 0.2 mL in prefilled syringe; 40 mg per 0.4 mL in prefilled syringe; 60 mg per 0.6 mL in prefilled syringe; 80 mg per 0.8 mL in prefilled syringe; 100 mg per 1 mL in prefilled syringe; 120 mg per 0.8 mL in prefilled syringe; 150 mg per 1 mL in prefilled syringe; 150 mg per 1 mL in ampoule; 20 mg per 0.2 mL in ampoule; 40 mg per 0.4 mL in ampoule; 60 mg per 0.6 mL in ampoule; 80 mg per 0.8 mL in ampoule; 100 mg per 1 mL in ampoule; 120 mg per 0.8 mL in ampoule Indications: - Venous thromboembolism - Acute ischaemic heart disease Source: EML workbook import
MOQ: 1
Kes0.00
Tranexamic Acid
Formulations: - Parenteral > General injections > IV: 100 mg per mL in 10 mL ampoule Indications: - Haemorrhage, not elsewhere classified - Postpartum haemorrhage Source: EML workbook import
MOQ: 1
Kes0.00
Sign Up to Our Newsletter→
Ready to amplify your rewards? Drop your email and we'll be in touch soon.